Seppo W. Langer

Seppo W. Langer

Clinical Associate Professor

Member of:

  • Clinical Oncology


  1. 2023
  2. Published

    Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms

    Morken, S., Langer, Seppo W., Sundlöv, A., Vestermark, L. W., Ladekarl, M., Hjortland, G. O., Svensson, J. B., Tabaksblat, E. M., Haslerud, T. M., Assmus, J., Detlefsen, S., Couvelard, A., Perren, A. & Sorbye, H., 2023, In: British Journal of Cancer. 129, p. 1930–1939 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Prospective Phase II Trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET/CT Imaging of Integrin αvβ3 for Prognostication in Patients with Neuroendocrine Neoplasms

    Carlsen, E. A., Loft, M., Loft, A., Czyzewska, D., Andreassen, Mikkel, Langer, Seppo W., Knigge, Ulrich & Kjær, Andreas, 2023, In: The Journal of Nuclear Medicine. 64, 2, p. 252-259

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan

    Mau-Sørensen, M., Gerner-Rasmussen, J., Hansen, O., Holm, B., Nyhus, C. H., McCulloch, T., Nielsen, H. A., Wedervang, K., Rytter, C., Jeppesen, N. & Langer, Seppo W., 2023, In: Acta Oncologica. 62, 12, p. 1-4 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Recurrence-Free Survival and Disease-Specific Survival in Patients with Pancreatic Neuroendocrine Neoplasms: A Single-Center Retrospective Study of 413 Patients

    Møller, S., Langer, Seppo W., Slott, C., Krogh, Jesper, Hansen, C. P., Kjær, Andreas, Holmager, P., Klose, M., Garbyal, Rajendra Singh, Knigge, Ulrich & Andreassen, Mikkel, 2023, In: Cancers. 16, 1, 14 p., 100.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Treatment of inoperable large cell neuroendocrine lung cancer with single agent temozolomide

    Ørting, A. M., Clausen, M. M., Soldath, Patrick, Petersen, René Horsleben, Knigge, Ulrich, Andreassen, Mikkel, Kjær, Andreas & Langer, Seppo W., 2023, In: Acta Oncologica. 62, 12, p. 1952-1955 4 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  7. 2022
  8. Published

    A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms

    Carlsen, E. A., Lindholm, Kristian, Hindsholm, A., Gæde, M., Ladefoged, C. N., Loft, M., Johnbeck, C. B., Langer, Seppo W., Oturai, P., Knigge, Ulrich, Kjær, Andreas & Andersen, Flemming Littrup, 2022, In: EJNMMI Research. 12, 1, p. 1-10 30.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Activity Dose Reduction in 64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability.

    Loft, M., Carlsen, Esben Andreas, Johnbeck, C. B., Jensen, C. V., Andersen, Flemming Littrup, Langer, Seppo W., Oturai, P., Knigge, Ulrich & Kjær, Andreas, 2022, In: Molecular Imaging and Biology. 24, p. 600–611

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study

    Mouritzen, M. T., Junker, K. F., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A-C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L. & 7 others, Homann, P. H., Kristensen, E. B., Drivsholm, L. B., Bøgsted, M., Christensen, H. S., Pøhl, M. & Bjørnhart, B., 2022, In: Acta Oncologica. 61, 4, p. 409-416

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    DLL3 expression and clinico-pathological data in 247 patients with NEN

    Clausen, Malene Martini, Federspiel, B., Carstensen, F., Suppli, M. H., Kjær, Andreas, Andreassen, Mikkel, Garbyal, Rajendra Singh, Knigge, Ulrich & Langer, Seppo W., 2022, In: Journal of Neuroendocrinology. 34, S1, p. 104 1 p.

    Research output: Contribution to journalConference abstract in journalResearch

  12. Published

    First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic

    Loft, Mathias Hougaard, Christensen, C., Clausen, Malene Martini, Carlsen, Esben Andreas, Hansen, C. P., Kroman, Niels Thorndahl, Langer, Seppo W., Høgdall, Claus Kim, Madsen, J., Gillings, N., Nielsen, Carsten Haagen, Klausen, Thomas Levin, Holm, S., Loft, A., Berthelsen, A. K. & Kjær, Andreas, 2022, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63, 12, p. 1871-1879

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...18 Next

ID: 33841728